Key Quantitative Figures
- No shares were dematerialized during the month of July 2026.
- The total number of dematerialized shares as of July 31, 2026, was 6,11,05,526.
- The breakdown by depository was: NSDL - 5,26,65,454 shares and CDSL - 84,40,072 shares.
Dates of Action and Reporting
The disclosure was dated and signed on August 05, 2026. The data reported is for the month ending July 31, 2026.
Parties Involved
The disclosure was made by Panacea Biotec Limited and was confirmed by the company's Registrar and Share Transfer Agent (RTA), Skyline Financial Services Pvt. Ltd. (SEBI Registered Category-1 RTA).
Financial and Capital Structure Impact
The disclosure confirms no change in the total number of dematerialized shares, indicating no impact on the company's capital structure for the reported month.
Confirmation from RTA
The company enclosed a certificate from Skyline Financial Services Pvt. Ltd. (Annexure-1) dated August 04, 2026, which provided the demat status report confirming the figures.
The document was signed by Ankit Jain, General Manager – Legal & Company Secretary of Panacea Biotec Limited.